WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareHealthcare Plans
Best Healthcare Plan Stocks to Buy Now (2023)
Top healthcare plan stocks in 2023 ranked by overall Zen Score. See the best healthcare plan stocks to buy now, according to analyst forecasts for the healthcare plans industry.

Industry: Healthcare Plans
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
MOH
MOLINA HEALTHCARE INC
$15.50B$267.72$357.8233.65%Buy113.76%46.21%45.71%11.00%
CI
CIGNA GROUP
$77.30B$260.21$325.4825.08%Buy215.80%12.71%N/AN/A
ELV
ELEVANCE HEALTH INC
$108.44B$456.69$531.6416.41%Strong Buy147.65%18.92%N/AN/A
UNH
UNITEDHEALTH GROUP INC
$444.03B$475.99$597.7125.57%Strong Buy178.26%14.09%45.70%14.47%
ALHC
ALIGNMENT HEALTHCARE INC
$1.16B$6.20$15.80154.84%Strong Buy1118.59%N/AN/AN/A
CNC
CENTENE CORP
$35.31B$64.05$93.8846.58%Buy17-1.75%201.44%17.53%5.49%
CLOV
CLOVER HEALTH INVESTMENTS CORP
$423.44M$0.88$1.89113.82%Hold428.24%N/AN/AN/A
CVS
CVS HEALTH CORP
$94.07B$73.26$117.3960.24%Strong Buy181.62%190.51%17.92%5.57%
HUM
HUMANA INC
$62.79B$502.43$588.8917.21%Strong Buy187.94%16.53%N/AN/A
OSCR
OSCAR HEALTH INC
$726.78M$3.36$5.0851.28%Hold616.71%N/A-16.76%-3.30%
BHG
BRIGHT HEALTH GROUP INC
$138.67M$0.22$1.57612.27%Sell499.39%N/A-40.87%1.76%
MRAI
MARPAI INC
$20.10M$0.96$2.50160.42%Strong Buy1N/AN/AN/AN/A
MPLN
MULTIPLAN CORP
$664.74M$1.04$1.4337.79%Hold3N/AN/A6.78%1.65%

Healthcare Plan Stocks FAQ

What are the best healthcare plan stocks to buy right now in Mar 2023?

According to Zen Score, the 3 best healthcare plan stocks to buy right now are:

1. Molina Healthcare (NYSE:MOH)


Molina Healthcare (NYSE:MOH) is the top healthcare plan stock with a Zen Score of 60, which is 24 points higher than the healthcare plan industry average of 36. It passed 19 out of 33 due diligence checks and has strong fundamentals. Molina Healthcare has seen its stock lose -20.68% over the past year, underperforming other healthcare plan stocks by -15 percentage points.

Molina Healthcare has an average 1 year price target of $357.82, an upside of 33.65% from Molina Healthcare's current stock price of $267.72.

Molina Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Molina Healthcare, 36.36% have issued a Strong Buy rating, 18.18% have issued a Buy, 36.36% have issued a hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.

2. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) is the second best healthcare plan stock with a Zen Score of 53, which is 17 points higher than the healthcare plan industry average of 36. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cigna Group has seen its stock return 7.48% over the past year, overperforming other healthcare plan stocks by 13 percentage points.

Cigna Group has an average 1 year price target of $325.48, an upside of 25.08% from Cigna Group's current stock price of $260.21.

Cigna Group stock has a consensus Buy recommendation according to Wall Street analysts. Of the 21 analysts covering Cigna Group, 42.86% have issued a Strong Buy rating, 19.05% have issued a Buy, 38.1% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Elevance Health (NYSE:ELV)


Elevance Health (NYSE:ELV) is the third best healthcare plan stock with a Zen Score of 47, which is 11 points higher than the healthcare plan industry average of 36. It passed 17 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -3.6% over the past year, overperforming other healthcare plan stocks by 2 percentage points.

Elevance Health has an average 1 year price target of $531.64, an upside of 16.41% from Elevance Health's current stock price of $456.69.

Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 14 analysts covering Elevance Health, 50% have issued a Strong Buy rating, 28.57% have issued a Buy, 21.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare plan stocks with highest dividends?

Out of 5 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

1. Cvs Health (NYSE:CVS)


Cvs Health (NYSE:CVS) has an annual dividend yield of 3.08%, which is 1 percentage points higher than the healthcare plan industry average of 1.6%. Cvs Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cvs Health's dividend has shown consistent growth over the last 10 years.

Cvs Health's dividend payout ratio of 71.4% indicates that its dividend yield is sustainable for the long-term.

2. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) has an annual dividend yield of 1.76%, which is the same as the healthcare plan industry average of 1.6%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 20.8% indicates that its dividend yield is sustainable for the long-term.

3. Unitedhealth Group (NYSE:UNH)


Unitedhealth Group (NYSE:UNH) has an annual dividend yield of 1.39%, which is the same as the healthcare plan industry average of 1.6%. Unitedhealth Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Unitedhealth Group's dividend has shown consistent growth over the last 10 years.

Unitedhealth Group's dividend payout ratio of 29.8% indicates that its dividend yield is sustainable for the long-term.

Why are healthcare plan stocks up?

Healthcare plan stocks were up 1.81% in the last day, and up 0.11% over the last week.

We couldn't find a catalyst for why healthcare plan stocks are up.

What are the most undervalued healthcare plan stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare plan stocks right now are:

1. Elevance Health (NYSE:ELV)


Elevance Health (NYSE:ELV) is the most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Elevance Health has a valuation score of 57, which is 30 points higher than the healthcare plan industry average of 27. It passed 4 out of 7 valuation due diligence checks.

Elevance Health's stock has dropped -3.6% in the past year. It has overperformed other stocks in the healthcare plan industry by 2 percentage points.

2. Molina Healthcare (NYSE:MOH)


Molina Healthcare (NYSE:MOH) is the second most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Molina Healthcare has a valuation score of 57, which is 30 points higher than the healthcare plan industry average of 27. It passed 4 out of 7 valuation due diligence checks.

Molina Healthcare's stock has dropped -20.68% in the past year. It has underperformed other stocks in the healthcare plan industry by -15 percentage points.

3. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) is the third most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Cigna Group has a valuation score of 57, which is 30 points higher than the healthcare plan industry average of 27. It passed 4 out of 7 valuation due diligence checks.

Cigna Group's stock has gained 7.48% in the past year. It has overperformed other stocks in the healthcare plan industry by 13 percentage points.

Are healthcare plan stocks a good buy now?

46.15% of healthcare plan stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare plan stocks to rise by 24.99% over the next year.

What is the average p/e ratio of the healthcare plans industry?

The average P/E ratio of the healthcare plans industry is 21.09x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.